🇺🇸 FDA
Pipeline program

E7080

E7080-J081-103

Phase 1 small_molecule completed

Quick answer

E7080 for Cancer: Solid Tumors is a Phase 1 program (small_molecule) at Eisai Co., with 1 ClinicalTrials.gov record(s).

Program details

Company
Eisai Co.,
Indication
Cancer: Solid Tumors
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials